<DOC>
	<DOC>NCT01018966</DOC>
	<brief_summary>The purpose of this study is to determine the DLT, MTD and recommended Phase II dose of ixabepilone in Japanese patients with solid tumors.</brief_summary>
	<brief_title>Study of Ixabepilone (BMS-247550) in Patients With Solid Tumors</brief_title>
	<detailed_description />
	<mesh_term>Epothilones</mesh_term>
	<criteria>20 years or older Histologically or cytologically confirmed diagnosis of adenocarcinoma Solid tumors Patients with an Eastern Cooperative Oncology Group (ECOG) performance status (PS) of â‰¥2</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>